V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20193109 | 20124172 | 1.52 | 77.85 | null | 2016-08-02 | 2016-10-11 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100567679 |
| 20193112 | 20124173 | 1.69 | null | Palliative (P) | 2020-04-28 | 2020-05-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101044910 |
| 20193114 | 20124174 | 1.7 | 68.5 | Neo-adjuvant (N) | 2017-09-29 | 2017-10-07 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101075229 |
| 20193115 | 20124175 | 1.7 | 108.5 | Adjuvant (A) | 2018-10-01 | 2018-10-01 | Cetuximab + FOLFIRI cycle1 | 02 | N | DOCETAXEL | 101173668 |
| 20193118 | 20124176 | 1.83 | 77 | Palliative (P) | 2019-08-19 | 2019-08-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100328879 |
| 20193121 | 20124177 | 1.66 | 99 | null | 2019-08-10 | 2019-08-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100612029 |
| 20193124 | 20124178 | 1.72 | 75.6 | null | 2020-09-03 | 2020-12-27 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100069051 |
| 20193126 | 20124179 | 1.69 | 83.6 | Neo-adjuvant (N) | 2017-11-08 | 2017-11-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101615205 |
| 20193130 | 20124180 | 1.74 | 67.5 | Palliative (P) | 2019-12-08 | 2019-12-27 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101424587 |
| 20193132 | 20124181 | 1.59 | 51.6 | Palliative (P) | 2016-06-10 | 2016-06-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101741250 |
| 20193134 | 20124182 | 1.59 | 81.4 | Palliative (P) | 2016-08-24 | 2016-09-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100875027 |
| 20193137 | 20124183 | 1.76 | 58 | Palliative (P) | 2018-12-10 | 2018-12-10 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100026242 |
| 20193139 | 20124184 | 1.89 | 72.05 | null | 2017-04-16 | 2017-11-15 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101308890 |
| 20193141 | 20124185 | 1.52 | 49.6 | Palliative (P) | 2016-05-29 | 2016-08-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101739134 |
| 20193147 | 20124186 | 1.83 | 71.6 | Palliative (P) | 2019-11-20 | 2019-12-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100461315 |
| 20193148 | 20124187 | 1.89 | 70 | null | null | 2019-01-18 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101519102 |
| 20193149 | 20124188 | 1.55 | 73.5 | Palliative (P) | 2018-02-09 | 2018-02-23 | Docetaxel | 02 | N | DOCETAXEL | 101101776 |
| 20193151 | 20124189 | 1.95 | 57.4 | null | 2017-04-01 | 2017-04-05 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101427081 |
| 20193154 | 20124190 | 1.63 | 49.1 | null | 2017-09-29 | 2017-10-16 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100474347 |
| 20193156 | 20124191 | 1.74 | 90.2 | null | 2016-09-29 | 2017-03-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101135305 |
| 20193157 | 20124192 | 1.76 | 86.9 | null | 2018-10-02 | 2018-10-07 | Docetaxel 100mg/m2 (21 day) | N | null | DOCETAXEL | 101666433 |
| 20193158 | 20124193 | 1.66 | 104.7 | Palliative (P) | 2016-02-07 | 2016-02-08 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101087682 |
| 20193159 | 20124194 | 1.67 | 72.55 | Palliative (P) | 2016-02-10 | 2016-03-23 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100223952 |
| 20193160 | 20124195 | 1.7 | 78.35 | Palliative (P) | 2015-07-13 | 2016-10-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101151609 |
| 20193162 | 20124196 | 1.67 | 67.6 | null | 2019-05-20 | 2019-05-20 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100643827 |
| 20193163 | 20124197 | 1.69 | 53 | Palliative (P) | 2017-04-29 | 2017-05-17 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 100066920 |
| 20193166 | 20124198 | 1.63 | 36.8 | Palliative (P) | 2016-08-09 | 2017-01-09 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100883744 |
| 20193170 | 20124199 | 1.7 | 73 | Palliative (P) | 2018-10-11 | 2018-10-13 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | DOCETAXEL | 100916670 |
| 20193172 | 20124200 | 1.8 | 81 | Palliative (P) | 2017-06-13 | 2018-05-15 | Docetaxel | 02 | N | DOCETAXEL | 100817337 |
| 20193173 | 20124201 | 1.74 | 79 | Palliative (P) | 2017-07-27 | 2017-08-09 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101673148 |
| 20193175 | 20124202 | 1.67 | 94.4 | Curative (C) | 2019-06-04 | 2019-12-14 | Docetaxel | 02 | N | DOCETAXEL | 101659401 |
| 20193178 | 20124203 | 1.59 | 70 | Palliative (P) | 2016-10-07 | 2017-03-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101305406 |
| 20193181 | 20124204 | 1.74 | 83.15 | Neo-adjuvant (N) | 2019-01-06 | 2019-01-09 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101794539 |
| 20193183 | 20124205 | 1.63 | 58.5 | Palliative (P) | 2019-09-19 | 2019-09-19 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | DOCETAXEL | 101109773 |
| 20193185 | 20124206 | 1.81 | 66 | Palliative (P) | 2017-10-16 | 2017-11-27 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100860928 |
| 20193188 | 20124207 | 1.9 | 64.5 | Adjuvant (A) | 2017-11-24 | 2017-12-15 | Docetaxel | 02 | N | DOCETAXEL | 101336147 |
| 20193189 | 20124208 | 1.78 | 103 | null | 2018-11-20 | 2018-12-08 | Docetaxel 75mg/m2 (21 day) | N | null | DOCETAXEL | 101045207 |
| 20193190 | 20124209 | 1.67 | 70.5 | Palliative (P) | 2018-10-14 | 2019-05-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100991742 |
| 20193191 | 20124210 | 1.88 | 46.1 | Palliative (P) | 2018-07-31 | 2018-08-08 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100803493 |
| 20193192 | 20124211 | 1.84 | 79.7 | Palliative (P) | 2018-12-14 | 2018-12-24 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101281972 |
| 20193193 | 20124212 | 1.74 | 58.35 | 02 | 2020-09-30 | 2021-04-22 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101486711 |
| 20193195 | 20124213 | 1.85 | 61 | Palliative (P) | 2017-10-09 | 2017-10-09 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101593362 |
| 20193197 | 20124214 | 1.74 | 58 | Palliative (P) | 2017-05-03 | 2017-05-11 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100179577 |
| 20193198 | 20124215 | 1.66 | 97.7 | Palliative (P) | 2018-03-31 | 2018-09-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100737639 |
| 20193200 | 20124216 | 1.69 | 53 | Palliative (P) | 2016-11-06 | 2016-11-07 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101065094 |
| 20193202 | 20124217 | 1.53 | 85 | Palliative (P) | 2019-11-05 | 2019-12-01 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100846692 |
| 20193204 | 20124218 | 1.63 | 77.2 | Adjuvant (A) | 2018-12-19 | 2018-12-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100083187 |
| 20193206 | 20124219 | 1.59 | 83.9 | Palliative (P) | 2018-04-01 | 2018-04-15 | Docetaxel | 02 | N | DOCETAXEL | 100916642 |
| 20193207 | 20124220 | 1.7 | 72.7 | null | 2017-07-28 | 2017-07-30 | Gemcitabine + Capecitabine | null | null | CAPECITABINE + GEMCITABINE | 101664227 |
| 20193211 | 20124221 | 1.76 | 95 | Adjuvant (A) | 2016-09-08 | 2017-11-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100935541 |